Versartis, Inc. (VSAR) - NASDAQ
  • Dan Rosenblum | Send Message 3 Mar

    Versartis: An Opportunity Amidst The Biotech Rubble $VSAR http://seekingalpha.com/a/2conu
    Reply
      • nsahbti | Send Message 9 Jul 2015

        $VSAR, $ASND: two long acting hGH developers. There are FIVE pharma with daily hGH who will likely license or acquire. Thoughts? LONG
        Reply
          • nsahbti | Send Message 9 Jul 2015

            $VSAR, @ASND: two long acting hGH developers. There are FIVE pharma with daily hGH who will likely license or acquire. Thoughts? LONG
            Reply
              • PatrickTS | Send Message 7 Jul 2015

                Stocks to watch on Tuesday 07.07.2015 $SGYP $SGNL $VSAR
                Reply
                  • Estella Jenkins | Send Message 7 Jul 2015

                    Pricing of biotech shares like $VSAR and $SGYP depend heavily on pushing new products, but the process is unpredictable. Look for shorting
                    Reply
                      • Yiwen Nni | Send Message 28 May 2015

                        $VSAR Anyone has any news?
                        Reply (5)
                      • View all 5 replies
                        • stocktrader | Send Message 28 May 2015
                          : stock is trading on unusual volume vs full-day 30-day moving average, without immediately obvious company-specific news. no idea why
                        • nsahbti | Send Message 2 Jul 2015
                          : Speculations as for the clinical hold at $VSAR?
                          • Kanak Kanti De | Send Message 12 May 2015

                            Versartis Has Upside Potential With Its Easier Compliance Dosage For GHD $VSAR http://seekingalpha.com/a/1w1k2
                            Reply
                              • StockStatus | Send Message 7 May 2015
                                Reply
                                  • C.R. Jackson | Send Message 4 Sep 2014

                                    Volatile Versartis May Have Significant Upside $VSAR http://seekingalpha.com/a/1gyqn
                                    Reply
                                      • Eric Muathe | Send Message 9 Jun 2014
                                        Reply
                                          Company Description
                                          Versartis, Inc. is an endocrine-focused biopharmaceutical company. It develops long-acting therapeutic proteins for the treatment of endocrine disorders. The company develops new therapeutic proteins utilizing the novel half-life extension technology XTEN. Versartis was founded by Jeffrey L.... More
                                          Sector: Healthcare
                                          Industry: Drugs - Generic
                                          Country: United States